<DOC>
	<DOCNO>NCT02440243</DOCNO>
	<brief_summary>Background There limited evidence indicate specific immunotherapy elderly patient safe effective . This study perform evaluate safety efficacy specific subcutaneous immunotherapy ( SCIT ) grass pollen allergens patient 60 year age seasonal allergic rhinitis ( SAR ) confirm allergy grass pollen . Objective This study assess safety efficacy SCIT grass pollen allergen elderly patient SAR . Methods This study include 62 60- 75-year-old patient SAR grass pollen allergy confirm use skin prick test , nasal provocation , serum IgE measurement . The patient individually randomize active placebo group use double-blinded method . There 33 subject SCIT group ( Purethal , Grass pollen , HAL Allergy B.V , Leiden , Netherlands ) 29 subject placebo group monitor three year . The patient require record use anti-allergy medication diary use visual graphic scale . The main outcome measure area curve ( AUC ) combine symptom medication score ( SMS ) .</brief_summary>
	<brief_title>Grass Pollen Subcutaneous Immunotherapy Elderly Patients</brief_title>
	<detailed_description>Methods Patients A total 109 patient range 60 70 year age recruit outpatient allergy clinic ass eligibility inclusion study . The subject moderate severe intermittent allergic rhinitis fulfil ARIA criterion . Additionally , patient include study positive skin prick test ( SPT ) , positive specific immunoglobulin E ( sIgE ) , positive nasal provocation test ( NPTs ) grass pollen mixture allergen . Patients follow characteristic exclude study : hypersensitivity allergen , bronchial asthma , non-allergic rhinitis ( especially senile vasomotor rhinitis ) severe non-stable disease . However , patient stable coronary disease , diabetes , arterial hypertension permit study . All subject require abstain anti-allergy drug glucocorticoid nasal drop least 6 week prior start study . There 62 patient individually randomize comparable number one two `` parallel '' group use double-blind method . The group active ( n=33 ) treatment group placebo ( n=29 ) group . There 31 subject SCIT group 25 subject placebo group complete three-year observation period . The group comparable baseline . Diagnostic procedure A careful examination eye , ear , nose , throat perform patient . The severity seasonal allergic rhinitis ( SAR ) assess use Allergic Rhinitis Impact Asthma ( ARIA ) guideline . The patient nasal problem chronic nasal obstruction , reduce olfaction , bacterial colonization , chronic sinusitis diagnose base CT scan nasal endoscopy . Several patient exclude observation result problem . The subject chronic acute clinical disorder history respiratory tract infection within four week study initiation also exclude . The SPT perform use inhalant allergen ( HAL Allergy B.V , Leiden , Netherlands ) follow panel : D. pteronyssinus , D. farinae , mixed 5 grass ( Phleum pratense , Dactylis glomerata , Anthoxanthum odoratum , Lolium perenne , Poa pratensis ) , mixed tree , mugwort , Alternaria , Cladosporium , dog cat allergen . There also positive ( 10 mg/ml histamine ) negative ( saline ) control include . A grass pollen allergy define positive skin test 5 grass pollen allergens minimum wheal diameter least 3 mm great negative control . The patient negative test histamine sensitivity exclude analysis . The sIgE reactivity single grass pollen allergen component ( Phl p1 , Phl p2 , Phl p5 , Phl p6 , Phl p7 Phl p12 ) determine use ImmunoCAP ( Phadia AB , Uppsala , Sweden ) test . The result consider positive sIgE concentration great 0.35 IU/ml ( accord manufacturer 's instruction ) . NPTs conduct use active anterior rhinomanometry commercial grass pollen mixture allergen . The concentration 10,000 AU/ml mixture deliver 1 puff per nostril ( HAL Allergy B.V , Leiden , Netherlands ) use method describe Bachert et al . Dordal et al . A reduction peak nasal inspiratory flow great equal 40 % increase symptom great equal 5 point consider positive NPT criterion Bachert et al . Dordal et al . The NPTs also repeat three year treatment . The patient monosensitized grass pollen include study . Treatments The patient randomly select receive Purethal Grasses 20,000 AUM/ml ( pollen mixture extract solution Agrostis stolonifera , Anthoxanthum odoratum , Arrhenatherum elatius , Dactylis glomerata , Festuca rubra , Holcus lanatus , Lolium perenne , Phleum pratense , Poa pratensis , Secale cereal , Loe edasi HAL Allergy B.V , Leiden , Netherlands ) placebo . The recruitment period limit three month ( October-December ) . Purethal grass ( January-April ) administer pre-seasonal therapy use follow regimen : 1 dose- 0.1 ml , 2 dose - 0.2 ml , 3 dose - 0.4 ml every week , dose 4- 7 consist 0.5 ml every two week . Using schedule average cumulative dose 460,500 BAU ( Bioequivalent Allergy Unit ) , contain approximately 690 Î¼g Phl p5 administer patient undergoing active treatment three year study . The study consist two phase . The first phase baseline one season follow-up visit without treatment second phase three year SCIT placebo . Assessment efficacy The prime outcome measure area curve ( AUC ) combine symptom medication score ( SMS ) grass pollen season baseline 2010 ( treatment ) 2011 , 2012 finally 2013 three year SCIT . The patient record symptom severity daily diary pollen season ( May-August ) score follow area : nasal itching , sneeze , run , blockage , ocular itch separate Visual Analog Scale ( VAS ) continuous scale 0 cm ( symptom ) 10 cm ( severe symptom ) . The rescue medication provide score one point per spray Azelastine nasal spray eye drop ( Levocabastine ) , per 5 mg levocetirizine tablet . The score two point per puff mometasone fuorate nasal spray three point per prednisolone 10 mg tablet . This combined symptom-medication score calculate sum symptom score medication score monitor daily use diary described . The SMS derive add VAS five symptom . The secondary outcome measure include quality life , reduction symptom score , safety assessment monitoring IgG4 . The local reaction assess 30 min injection measure cm . The systemic reaction grade accord EAACI criterion . Serum IgG4 measurements The serum concentration IgG4 birch alder hazel pollen determine blood serum ELISA test accord Lai et al . three-year SIT . Quality life Patient quality life evaluate RQLQ score adult use questionnaire every grass pollen season study . Pollen count The local grass pollen count determine volumetric pollen trap ( Burkard , Scientific Ltd , Uxbridge , UK ) . The peak pollen count define day high grass pollen count season 3 week 3 week peak grass pollen count .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>positive skin prick test ( SPT ) , positive specific immunoglobulin E ( sIgE ) , positive nasal provocation test ( NPTs ) grass pollen mixture allergens hypersensitivity allergen , bronchial asthma , nonallergic rhinitis ( especially senile vasomotor rhinitis ) severe nonstable disease .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>